These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 18507037)

  • 1. Positive correlation of cell-free DNA in plasma/serum in patients with malignant and benign breast disease.
    Zanetti-Dällenbach R; Wight E; Fan AX; Lapaire O; Hahn S; Holzgreve W; Zhong XY
    Anticancer Res; 2008; 28(2A):921-5. PubMed ID: 18507037
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated level of cell-free plasma DNA is associated with breast cancer.
    Zhong XY; Ladewig A; Schmid S; Wight E; Hahn S; Holzgreve W
    Arch Gynecol Obstet; 2007 Oct; 276(4):327-31. PubMed ID: 17431649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of serum VEGF and its soluble receptor sVEGFR1 with serum cell-free DNA in patients with breast tumor.
    El Tarhouny S; Seefeld M; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Cytokine; 2008 Oct; 44(1):65-9. PubMed ID: 18691902
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Levels of circulating cell-free serum DNA in benign and malignant breast lesions.
    Zanetti-Dällenbach RA; Schmid S; Wight E; Holzgreve W; Ladewing A; Hahn S; Zhong XY
    Int J Biol Markers; 2007; 22(2):95-9. PubMed ID: 17549664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative analysis of plasma circulating DNA at diagnosis and during follow-up of breast cancer patients.
    Huang ZH; Li LH; Hua D
    Cancer Lett; 2006 Nov; 243(1):64-70. PubMed ID: 16412565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA integrity in plasma and serum of patients with malignant and benign diseases.
    Holdenrieder S; Burges A; Reich O; Spelsberg FW; Stieber P
    Ann N Y Acad Sci; 2008 Aug; 1137():162-70. PubMed ID: 18837942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cell-free tumour DNA and RNA in patients with breast cancer and benign breast disease.
    Schwarzenbach H; Müller V; Milde-Langosch K; Steinbach B; Pantel K
    Mol Biosyst; 2011 Oct; 7(10):2848-54. PubMed ID: 21785770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating hTERT DNA in early breast cancer.
    Divella R; Tommasi S; Lacalamita R; Daniele A; Abbate I; Garrisi VM; Savino E; Coviello M; Rubini V; Simone G; Paradiso A; Quaranta M
    Anticancer Res; 2009 Jul; 29(7):2845-9. PubMed ID: 19596972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concentrations of circulating RNA from healthy donors and cancer patients estimated by different methods.
    Rykova EY; Wunsche W; Brizgunova OE; Skvortsova TE; Tamkovich SN; Senin IS; Laktionov PP; Sczakiel G; Vlassov VV
    Ann N Y Acad Sci; 2006 Sep; 1075():328-33. PubMed ID: 17108228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and lipid-bound serum sialic acid in benign and malignant breast disease.
    Romppanen J; Eskelinen M; Tikanoja S; Mononen I
    Anticancer Res; 1997; 17(2B):1249-53. PubMed ID: 9137482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of plasma DNA as a screening tool for lung cancer.
    Xie GS; Hou AR; Li LY; Gao YN; Cheng SJ
    Chin Med J (Engl); 2004 Oct; 117(10):1485-8. PubMed ID: 15498370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of some trace elements concentration in blood, tumor free breast and tumor tissues of women with benign and malignant breast lesions: an Indian study.
    Siddiqui MK; Jyoti ; Singh S; Mehrotra PK; Singh K; Sarangi R
    Environ Int; 2006 Jul; 32(5):630-7. PubMed ID: 16580070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of circulating cell-free nuclear and mitochondrial DNA in benign and malignant ovarian tumors.
    Zachariah RR; Schmid S; Buerki N; Radpour R; Holzgreve W; Zhong X
    Obstet Gynecol; 2008 Oct; 112(4):843-50. PubMed ID: 18827127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of the menstrual cycle on circulating cell-free DNA.
    Pölcher M; Ellinger J; Willems S; El-Maarri O; Höller T; Amann C; Wolfgarten M; Rudlowski C; Kuhn W; Braun M
    Anticancer Res; 2010 Jun; 30(6):2235-40. PubMed ID: 20651374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Significance of serum ferritin and lactate dehydrogenase in benign and malignant disease of breast.
    Kher A; Moghe G; Deshpande A
    Indian J Pathol Microbiol; 1997 Jul; 40(3):321-6. PubMed ID: 9354001
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced plasma RNA integrity in nasopharyngeal carcinoma patients.
    Wong BC; Chan KC; Chan AT; Leung SF; Chan LY; Chow KC; Lo YM
    Clin Cancer Res; 2006 Apr; 12(8):2512-6. PubMed ID: 16638860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher amount of free circulating DNA in serum than in plasma is not mainly caused by contaminated extraneous DNA during separation.
    Umetani N; Hiramatsu S; Hoon DS
    Ann N Y Acad Sci; 2006 Sep; 1075():299-307. PubMed ID: 17108224
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parallel assessment of circulatory cell-free DNA by PCR and nucleosomes by ELISA in breast tumors.
    Seefeld M; El Tarhouny S; Fan AX; Hahn S; Holzgreve W; Zhong XY
    Int J Biol Markers; 2008; 23(2):69-73. PubMed ID: 18629778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smoking in pregnancy is associated with increased total maternal serum cell-free DNA levels.
    Urato AC; Peter I; Canick J; Lambert-Messerlian G; Pulkkinen A; Knight G; Jeong YJ; Johnson KL; Bianchi DW
    Prenat Diagn; 2008 Mar; 28(3):186-90. PubMed ID: 18260159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular domain of HER2: a useful marker for the initial workup and follow-up of HER2-positive breast cancer.
    Garoufali A; Kyriakou F; Kountourakis P; Yioti I; Malliou S; Nikaki A; Kardara E; Frangos I; Koumna S; Baziotis N; Scorilas A; Ardavanis A
    J BUON; 2008; 13(3):409-13. PubMed ID: 18979558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.